Aroa Biosurgery Limited (ASX: ARX)
Australia
· Delayed Price · Currency is AUD 0.740
0.00 (0.00%)
Jan 21, 2025, 4:10 PM AEST
Aroa Biosurgery Revenue
Aroa Biosurgery had revenue of 39.16M NZD in the half year ending September 30, 2024, with 33.47% growth. This brings the company's revenue in the last twelve months to 76.35M, up 15.87% year-over-year. In the fiscal year ending March 31, 2024, Aroa Biosurgery had annual revenue of 69.07M with 9.01% growth.
Revenue (ttm)
76.35M NZD
Revenue Growth
+15.87%
P/S Ratio
3.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
255.23M AUD
Revenue Chart
* This company reports financials in NZD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| Pro Medicus | 161.50M |
| Cochlear | 2.24B |
| Sonic Healthcare | 8.97B |
| Telix Pharmaceuticals | 645.68M |
| Ramsay Health Care | 16.66B |
| Ansell | 2.43B |
| Sigma Healthcare | 3.48B |
Aroa Biosurgery News
- 7 weeks ago - Aroa Biosurgery Ltd (ASX:ARX) H1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus